Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence: response to comments by Ezziddin et al.

被引:0
|
作者
Campana, Davide [1 ,4 ]
Delle Fave, Gianfranco [2 ]
Falconi, Massimo [3 ]
Tommassetti, Paola [1 ]
机构
[1] Univ Bologna, Dept Med & Surg Sci, Policlin S Orsola Malpighi, I-40138 Bologna, Italy
[2] Univ Roma La Sapienza, Digest & Liver Dis Unit, I-00185 Rome, Italy
[3] Univ Politecn Marche, Dept Surg, Ancona, Italy
[4] Univ Bologna, Dept Clin Med, Policlin S Orsola Malpighi, I-40138 Bologna, Italy
关键词
PANCREATIC ENDOCRINE TUMORS; DISEASE PROGRESSION; PROGNOSTIC-FACTORS; GRADING SYSTEM; SURVIVAL; TOXICITY;
D O I
10.1007/s00259-013-2603-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:176 / 177
页数:2
相关论文
共 50 条
  • [1] Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence: response to comments by Ezziddin et al.
    Davide Campana
    Gianfranco Delle Fave
    Massimo Falconi
    Paola Tommassetti
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 176 - 177
  • [2] Comment on Campana et al.: Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence
    Ezziddin, Samer
    Sabet, Amir
    Yong-Hing, Charlotte Jane
    Biersack, Hans-Juergen
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (01) : 174 - 175
  • [3] Comment on Campana et al.: Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence
    Samer Ezziddin
    Amir Sabet
    Charlotte Jane Yong-Hing
    Hans-Jürgen Biersack
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 174 - 175
  • [4] Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence
    Campana, Davide
    Capurso, Gabriele
    Partelli, Stefano
    Nori, Francesca
    Panzuto, Francesco
    Tamburrino, Domenico
    Cacciari, Giulia
    Delle Fave, Gianfranco
    Falconi, Massimo
    Tomassetti, Paola
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (08) : 1197 - 1205
  • [5] Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence
    Davide Campana
    Gabriele Capurso
    Stefano Partelli
    Francesca Nori
    Francesco Panzuto
    Domenico Tamburrino
    Giulia Cacciari
    Gianfranco Delle Fave
    Massimo Falconi
    Paola Tomassetti
    European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 1197 - 1205
  • [6] A rapid rise in circulating pancreastatin in response to somatostatin analogue therapy is associated with poor survival in patients with neuroendocrine tumours
    Stronge, R. L.
    Turner, G. B.
    Johnston, B. T.
    McCance, D. R.
    McGinty, A.
    Patterson, C. C.
    Ardill, J. E. S.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2008, 45 : 560 - 566
  • [7] Response to the Comments on Rimassa et al.: "Systemic Treatment Options in Hepatocellular Carcinoma"
    Rimassa, Lorenza
    Pressiani, Tiziana
    Merle, Philippe
    LIVER CANCER, 2020, 9 (02) : 223 - 224
  • [8] Comments on the authors' response to the comments on "Factors influencing the removal of divalent cations by hydroxyapatite", by Smicilklas et al.
    Milonjic, Slobodan K.
    JOURNAL OF HAZARDOUS MATERIALS, 2010, 176 (1-3) : 1126 - 1127
  • [9] Response to comments on 'Malignant mesothelioma diagnosed at a younger age is associated with heavier asbestos exposure' by Farioli et al. and Oddone et al.
    Dragani, Tommaso A.
    Colombo, Francesca
    Pavlisko, Elizabeth N.
    Roggli, Victor L.
    CARCINOGENESIS, 2019, 40 (03) : 490 - 491
  • [10] Factors affecting biomarkers of endothelial and alveolar epithelial dysfunction: response to comments by Kyo et al.
    Nadir Yehya
    Neal J. Thomas
    Nuala J. Meyer
    Susan S. Margulies
    Intensive Care Medicine, 2016, 42 : 2113 - 2114